
A new study from the laboratory of Gemma Carvill, PhD, has uncovered variants in noncoding regulatory regions of the genome that contribute to the development of neurodevelopmental disorders, findings that could help spearhead the development of more effective precision therapeutic strategies.

A landmark international study has found that the genetic drivers of Parkinson’s disease can vary dramatically between populations, underscoring the need to include people of various ancestries in genetic research and clinical trials.

Northwestern Medicine scientists have uncovered how a major Parkinson’s disease gene disrupts the brain’s most vulnerable dopamine-producing neurons before detectable neuronal loss, according to findings published in Nature Communications.

A recent Northwestern Medicine study offers new data showing previously unknown genetic variants that cause the development of tuberous sclerosis complex, a rare genetic disorder that causes benign tumors to develop in many parts of the body, according to findings published in Nature Communications.

A new study from Northwestern Medicine investigators, in collaboration with Biohub, a program of the Chan Zuckerberg Initiative, has identified potential drug targets for treating psoriasis, according to the study published in Nature Communications.

A Northwestern Medicine study has uncovered how chronic defects in muscle membrane repair can fuel harmful inflammation, according to the study published in JCI Insight.

For the first time, Northwestern Medicine scientists have detailed how autumn and spring daylight saving time transitions impact a person’s risk of developing retinal vascular disease, according to a recent study published in Scientific Reports.

A new Northwestern Medicine study has discovered how radiotherapy alters the immune environment within cutaneous T-cell lymphoma tumors, revealing new molecular signatures associated with long-term treatment response and tumor recurrence.

Northwestern scientists have identified a novel mechanism utilized by the bacteria responsible for gonorrhea to evade immune detection and achieve widespread infection, according to a recent study published in the Proceedings of the National Academy of Sciences.

A new immunotherapy strategy has shown promise in targeting one of the most aggressive and deadly forms of brain cancer, according to a new study published in Nature.
Notifications